AKI is a sudden and rapid deterioration of kidney function, as a result of a serious illness, such as COVID-19. The most recent data shows that AKI can occur in up to 31% of patients on ventilators and 4% of those not on ventilators.
- To let families and patients know about the charities which are there to support them, such as Kidney Care UK.
- To have a full discussion with patients and families to make informed decisions about treatments
- To find out whether patients have made any advance decisions about their care, which should be taken into account (Kidney Care UK strongly believes that there should be no blanket, only personalised decisions about care)
- To assess for risk of AKI, as there is some evidence that COVID-19 harms the kidneys
- To monitor and manage fluids, giving them intravenously if necessary (AKI often means a patient stops weeing)
- To watch out for and treat high potassium (hyperkalaemia) which can build up and become dangerous
- To seek further specialist advice if deterioration continues for more than 48 hours
- To use existing guidance in providing renal replacement therapy (dialysis) treatments
- To monitor the kidney function of patients who recover for the following 2-3 years
See the full guidance on the NICE website